Voyageur Pharmaceuticals Ltd (VM) — Cash Flow-to-Debt Ratio
Voyageur Pharmaceuticals Ltd (VM) has a Cash Flow-to-Debt Ratio of -0.20x as of November 2025, meaning its operating cash flow of CA$-369.98K could theoretically repay 0% of its total liabilities (CA$1.85 Million) in one year. Check Voyageur Pharmaceuticals Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Voyageur Pharmaceuticals Ltd Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Voyageur Pharmaceuticals Ltd across 15 annual periods. Also explore Voyageur Pharmaceuticals Ltd asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Voyageur Pharmaceuticals Ltd (2011–2025)
Year-by-year debt coverage analysis for Voyageur Pharmaceuticals Ltd. For market capitalisation and broader financial context, see Voyageur Pharmaceuticals Ltd stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.56x | CA$-2.89 Million | CA$1.85 Million | ▼ -1009.7% |
| 2024 | -0.14x | CA$-302.29K | CA$2.15 Million | ▲ +89.7% |
| 2023 | -1.36x | CA$-991.25K | CA$727.88K | ▲ +50.0% |
| 2022 | -2.72x | CA$-1.72 Million | CA$630.83K | ▼ -8.8% |
| 2021 | -2.50x | CA$-1.65 Million | CA$660.64K | ▼ -791.3% |
| 2020 | -0.28x | CA$-272.19K | CA$968.85K | ▲ +62.4% |
| 2019 | -0.75x | CA$-637.81K | CA$852.69K | ▼ -14.5% |
| 2018 | -0.65x | CA$-490.45K | CA$750.79K | ▼ -0.4% |
| 2017 | -0.65x | CA$-624.24K | CA$959.12K | ▲ +27.9% |
| 2016 | -0.90x | CA$-35.07K | CA$38.86K | ▲ +88.1% |
| 2015 | -7.61x | CA$-70.65K | CA$9.28K | ▼ -2424.0% |
| 2014 | -0.30x | CA$-23.66K | CA$78.45K | ▲ +95.3% |
| 2013 | -6.38x | CA$-54.73K | CA$8.58K | ▼ -6561.2% |
| 2012 | 0.10x | CA$2.32K | CA$23.47K | ▲ +107.4% |
| 2011 | -1.33x | CA$-28.19K | CA$21.21K | — |